Earnings Call Insights: Annexon (ANNX) Q2 2026
Annexon Biosciences, Inc. (ANNX), a clinical-stage biopharmaceutical company focused on developing novel therapies for complement-mediated autoimmune, neurodegenerative, and ophthalmic diseases, convened its highly anticipated second-quarter 2026 earnings call on .…
